Cold plasma could save limbs in diabetic patients
NCT ID NCT07073040
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding cold atmospheric plasma to standard artery-opening treatment helps heal diabetic foot ulcers faster. About 86 adults with diabetes and blocked leg arteries will receive either real or fake plasma sessions over two weeks. The goal is to see if the plasma reduces wound size and prevents infection.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- cold atmospheric plasma (device)
- What this could lead to
- If it works, this could provide a new, safe way to help heal stubborn diabetic foot ulcers and lower the risk of amputation.
- What could go wrong
- This is a small, early-stage trial with only 86 participants. The added benefit of plasma over standard care may be modest, and the device requires multiple sessions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC FOOT ULCERS (DFU) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ansteel General Hospital
RECRUITINGAnshan, Liaoning, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.